U.S. markets closed

China Pharma Holdings, Inc. (CPHI)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4723-0.0142 (-2.92%)
At close: 12:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close0.4865
Open0.4865
Bid0.4600 x 4000
Ask0.4760 x 800
Day's Range0.4600 - 0.4865
52 Week Range0.2200 - 1.4000
Volume480,480
Avg. Volume458,809
Market Cap20.583M
Beta (5Y Monthly)0.45
PE Ratio (TTM)N/A
EPS (TTM)-0.4680
Earnings DateNov 13, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results
    PR Newswire

    China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.

  • A Quick Analysis On China Pharma Holdings' (NYSEMKT:CPHI) CEO Salary
    Simply Wall St.

    A Quick Analysis On China Pharma Holdings' (NYSEMKT:CPHI) CEO Salary

    This article will reflect on the compensation paid to Zhilin Li who has served as CEO of China Pharma Holdings, Inc...

  • China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks
    PR Newswire

    China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that the masks produced by its subsidiary Hainan Helpson Medicine & Biotechniqe Co., Ltd. has received multiple certifications, and have been listed on the Whitelist ("Whitelist" refers to the "List of Non-Medical Mask Manufacturers that have Obtained Foreign Standard Certification or Registration" and "List of Medical Material Production Enterprises that have Obtained Foreign Standard Certification or Registration" as indicated in document No. 12 issued by the Chinese government in 2020).